{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:56:11Z","timestamp":1790646971978,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T00:00:00Z","timestamp":1564963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"SACYL NHS","award":["BIO\/SA\/12\/13"],"award-info":[{"award-number":["BIO\/SA\/12\/13"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00296-019-04406-5","type":"journal-article","created":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T06:02:37Z","timestamp":1564984957000},"page":"303-311","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0151-5420","authenticated-orcid":false,"given":"Luis","family":"Corral-Gudino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3362-6451","authenticated-orcid":false,"given":"Elvira","family":"Gonz\u00e1lez-V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0553-6157","authenticated-orcid":false,"given":"Ismael","family":"Calero-Paniagua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1756-3507","authenticated-orcid":false,"given":"Laura","family":"P\u00e9rez-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4984-0639","authenticated-orcid":false,"given":"Ivan","family":"Cusacovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7301-7637","authenticated-orcid":false,"given":"Alicia","family":"Rivas-Lamazares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6648-3645","authenticated-orcid":false,"given":"Alba","family":"Quesada-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5872-0594","authenticated-orcid":false,"given":"Ana","family":"Gonz\u00e1lez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5113-5077","authenticated-orcid":false,"given":"Damian","family":"Mora-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5054-0211","authenticated-orcid":false,"given":"Jose Luis","family":"Lerma-M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3145-6137","authenticated-orcid":false,"given":"Javier","family":"del-Pino-Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,5]]},"reference":[{"key":"4406_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40620-017-0412-z","volume":"31","author":"V Binda","year":"2018","unstructured":"Binda V, Moroni G, Messa P (2018) ANCA-associated vasculitis with renal involvement. J Nephrol 31:197\u2013208. \nhttps:\/\/doi.org\/10.1007\/s40620-017-0412-z","journal-title":"J Nephrol"},{"key":"4406_CR2","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/art.1780330807","volume":"33","author":"RY Leavitt","year":"1990","unstructured":"Leavitt RY, Fauci AS, Bloch DA et al (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener\u2019s granulomatosis. Arthritis Rheum 33:1101\u20131107","journal-title":"Arthritis Rheum"},{"key":"4406_CR3","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/art.1780330806","volume":"33","author":"AT Masi","year":"1990","unstructured":"Masi AT, Hunder GG, Lie JT et al (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 33:1094\u20131100","journal-title":"Arthritis Rheum"},{"key":"4406_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/art.1780370206","volume":"37","author":"JC Jennette","year":"1994","unstructured":"Jennette JC, Falk RJ, Andrassy K et al (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37:187\u2013192","journal-title":"Arthritis Rheum"},{"key":"4406_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311. \nhttps:\/\/doi.org\/10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"4406_CR6","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1136\/ard.59.6.478","volume":"59","author":"SF S\u00f8rensen","year":"2000","unstructured":"S\u00f8rensen SF, Slot O, Tvede N, Petersen J (2000) A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature. Ann Rheum Dis 59:478\u2013482","journal-title":"Ann Rheum Dis"},{"key":"4406_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1136\/ard.2006.054593","volume":"66","author":"R Watts","year":"2007","unstructured":"Watts R, Lane S, Hanslik T et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222\u2013227. \nhttps:\/\/doi.org\/10.1136\/ard.2006.054593","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 111","key":"4406_CR8","first-page":"85","volume":"36","author":"J Yoo","year":"2018","unstructured":"Yoo J, Kim HJ, Ahn SS et al (2018) The utility of the ACR\/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis. Clin Exp Rheumatol 36(Suppl 111):85\u201387","journal-title":"Clin Exp Rheumatol"},{"key":"4406_CR9","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/ard.2009.119032","volume":"69","author":"N Basu","year":"2010","unstructured":"Basu N, Watts R, Bajema I et al (2010) EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis. Ann Rheum Dis 69:1744\u20131750. \nhttps:\/\/doi.org\/10.1136\/ard.2009.119032","journal-title":"Ann Rheum Dis"},{"key":"4406_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1093\/rheumatology\/36.4.453","volume":"36","author":"IN Bruce","year":"1997","unstructured":"Bruce IN, Bell AL (1997) A comparison of two nomenclature systems for primary systemic vasculitis. Br J Rheumatol 36:453\u2013458","journal-title":"Br J Rheumatol"},{"key":"4406_CR11","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1093\/qjmed\/hci015","volume":"98","author":"SE Lane","year":"2005","unstructured":"Lane SE, Watts RA, Shepstone L, Scott DGI (2005) Primary systemic vasculitis: clinical features and mortality. QJM 98:97\u2013111. \nhttps:\/\/doi.org\/10.1093\/qjmed\/hci015","journal-title":"QJM"},{"key":"4406_CR12","doi-asserted-by":"publisher","first-page":"3452","DOI":"10.1002\/art.34562","volume":"64","author":"S Lionaki","year":"2012","unstructured":"Lionaki S, Blyth ER, Hogan SL et al (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 64:3452\u20133462. \nhttps:\/\/doi.org\/10.1002\/art.34562","journal-title":"Arthritis Rheum"},{"key":"4406_CR13","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/rheumatology\/41.10.1138","volume":"41","author":"SE Lane","year":"2002","unstructured":"Lane SE, Watts RA, Barker THW, Scott DGI (2002) Evaluation of the S\u00f8rensen diagnostic criteria in the classification of systemic vasculitis. Rheumatology (Oxford) 41:1138\u20131141","journal-title":"Rheumatology (Oxford)"},{"key":"4406_CR14","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/annrheumdis-2012-201750","volume":"72","author":"A Mahr","year":"2013","unstructured":"Mahr A, Katsahian S, Varet H et al (2013) Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis 72:1003\u20131010. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2012-201750","journal-title":"Ann Rheum Dis"},{"key":"4406_CR15","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1002\/art.37892","volume":"65","author":"L Corral-Gudino","year":"2013","unstructured":"Corral-Gudino L et al (2013) Antineutrophil cytoplasmic autoantibodies: an unbiased and efficient tool to classify renal vasculitis? Comment on the article by Lionaki et al. Arthritis Rheum 65:1405\u20131406. \nhttps:\/\/doi.org\/10.1002\/art.37892","journal-title":"Arthritis Rheum"},{"key":"4406_CR16","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1002\/art.39812","volume":"68","author":"EM Miloslavsky","year":"2016","unstructured":"Miloslavsky EM, Lu N, Unizony S et al (2016) Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive and ANCA-negative patients with granulomatosis with polyangiitis (Wegener\u2019s): distinct patient subsets. Arthritis Rheumatol (Hoboken, NJ) 68:2945\u20132952. \nhttps:\/\/doi.org\/10.1002\/art.39812","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"4406_CR17","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1002\/art.39786","volume":"68","author":"JH Schirmer","year":"2016","unstructured":"Schirmer JH, Wright MN, Herrmann K et al (2016) Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-positive granulomatosis with polyangiitis (Wegener\u2019s) is a clinically distinct subset of ANCA-associated vasculitis: a retrospective analysis of 315 patients from a German vasculitis referral center. Arthritis Rheumatol (Hoboken, NJ) 68:2953\u20132963. \nhttps:\/\/doi.org\/10.1002\/art.39786","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"4406_CR18","doi-asserted-by":"publisher","first-page":"e6083","DOI":"10.1097\/MD.0000000000006083","volume":"96","author":"R Solans-Laqu\u00e9","year":"2017","unstructured":"Solans-Laqu\u00e9 R, Fraile G, Rodriguez-Carballeira M et al (2017) Clinical characteristics and outcome of Spanish patients with ANCA-associated vasculitides: impact of the vasculitis type, ANCA specificity, and treatment on mortality and morbidity. Medicine (Baltimore) 96:e6083. \nhttps:\/\/doi.org\/10.1097\/MD.0000000000006083","journal-title":"Medicine (Baltimore)"},{"key":"4406_CR19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez016","author":"S Deshayes","year":"2019","unstructured":"Deshayes S, Martin Silva N, Khoy K et al (2019) Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification. Rheumatology (Oxford). \nhttps:\/\/doi.org\/10.1093\/rheumatology\/kez016","journal-title":"Rheumatology (Oxford)"},{"key":"4406_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3352\/jeehp.2013.10.12","volume":"10","author":"M Vassar","year":"2013","unstructured":"Vassar M, Holzmann M (2013) The retrospective chart review: important methodological considerations. J Educ Eval Health Prof 10:12. \nhttps:\/\/doi.org\/10.3352\/jeehp.2013.10.12","journal-title":"J Educ Eval Health Prof"},{"key":"4406_CR21","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1136\/ard.2008.101279","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Lee R, Brown D et al (2009) Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis 68:1827\u20131832. \nhttps:\/\/doi.org\/10.1136\/ard.2008.101279","journal-title":"Ann Rheum Dis"},{"key":"4406_CR22","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612","journal-title":"Ann Intern Med"},{"key":"4406_CR23","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1136\/ard.2008.088096","volume":"68","author":"C Mukhtyar","year":"2009","unstructured":"Mukhtyar C, Guillevin L, Cid MC et al (2009) EULAR recommendations for the management of primary small and medium vessel vasculitis. Ann Rheum Dis 68:310\u2013317. \nhttps:\/\/doi.org\/10.1136\/ard.2008.088096","journal-title":"Ann Rheum Dis"},{"key":"4406_CR24","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"M Yates","year":"2016","unstructured":"Yates M, Watts RA, Bajema IM et al (2016) EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 75:1583\u20131594. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2016-209133","journal-title":"Ann Rheum Dis"},{"key":"4406_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/art.1780400222","volume":"40","author":"AR Exley","year":"1997","unstructured":"Exley AR, Bacon PA, Luqmani RA et al (1997) Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides. Arthritis Rheum 40:371\u2013380","journal-title":"Arthritis Rheum"},{"key":"4406_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00005792-198403000-00001","volume":"63","author":"JG Lanham","year":"1984","unstructured":"Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg\u2013Strauss syndrome. Medicine (Baltimore) 63:65\u201381","journal-title":"Medicine (Baltimore)"},{"key":"4406_CR27","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1002\/art.24790","volume":"61","author":"PA Gatenby","year":"2009","unstructured":"Gatenby PA, Lucas RM, Engelsen O et al (2009) Antineutrophil cytoplasmic antibody-associated vasculitides: could geographic patterns be explained by ambient ultraviolet radiation? Arthritis Rheum 61:1417\u20131424. \nhttps:\/\/doi.org\/10.1002\/art.24790","journal-title":"Arthritis Rheum"},{"key":"4406_CR28","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.3899\/jrheum.110650","volume":"38","author":"L Corral-Gudino","year":"2011","unstructured":"Corral-Gudino L, Borao-Cengotita-Bengoa M, Lerma-Marquez JL, del Pino-Montes J (2011) Differences in the incidence of microscopic polyangiitis and granulomatosis with polyangiitis (Wegener\u2019s). Is there a latitudinal gradient? J Rheumatol 38:2494\u20132496. \nhttps:\/\/doi.org\/10.3899\/jrheum.110650","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"4406_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1365-2249.2011.04358.x","volume":"164","author":"RA Luqmani","year":"2011","unstructured":"Luqmani RA, Suppiah R, Grayson PC et al (2011) Nomenclature and classification of vasculitis\u2014update on the ACR\/EULAR diagnosis and classification of vasculitis study (DCVAS). Clin Exp Immunol 164(Suppl 1):11\u201313. \nhttps:\/\/doi.org\/10.1111\/j.1365-2249.2011.04358.x","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"4406_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/1756-185X.13304","volume":"22","author":"RA Watts","year":"2019","unstructured":"Watts RA (2019) Evolving concepts in classification of systemic vasculitis: where are we and what is the way forward? Int J Rheum Dis 22(Suppl 1):21\u201327. \nhttps:\/\/doi.org\/10.1111\/1756-185X.13304","journal-title":"Int J Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-019-04406-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-019-04406-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T23:16:27Z","timestamp":1596496587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-019-04406-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,5]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["4406"],"URL":"https:\/\/doi.org\/10.1007\/s00296-019-04406-5","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,5]]},"assertion":[{"value":"18 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Del-Pino-Montes, Javier: Consultancies, speaking fees, and honoraria (<\u200910,000$) Amgen, BMS, Celgene, FAES, Gebro, Janssen, Lilly, Novartis, Pfizer, Roche, Sanofi. The rest of authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}